{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:29:48Z","timestamp":1788218988662,"version":"build-2803163510"},"reference-count":144,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jbc.2024.107264","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:40:21Z","timestamp":1712277621000},"page":"107264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Applications of protein ubiquitylation and deubiquitylation in drug discovery"],"prefix":"10.1016","volume":"300","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1903-3657","authenticated-orcid":false,"given":"Yilin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6599-2634","authenticated-orcid":false,"given":"Haoan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107264_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107264_bib3","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107264_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"AUTACs: Cargo-specific degraders using selective autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.107264_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","article-title":"Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds","volume":"575","author":"Li","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41589-022-00971-2","article-title":"Deubiquitinase-targeting chimeras for targeted protein stabilization","volume":"18","author":"Henning","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-cellbio-120420-091943","article-title":"Physiological functions of intracellular protein degradation","volume":"38","author":"McShane","year":"2022","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-biochem-061516-044859","article-title":"The ubiquitin system, autophagy, and regulated protein degradation","volume":"86","author":"Varshavsky","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2024.107264_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-cellbio-100617-062802","article-title":"Principles of ubiquitin-dependent signaling","volume":"34","author":"Oh","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","article-title":"The different autophagy degradation pathways and neurodegeneration","volume":"110","author":"Fleming","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.107264_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2024.107264_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","article-title":"An expanded lexicon for the ubiquitin code","volume":"24","author":"Dikic","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ncb3358","article-title":"The increasing complexity of the ubiquitin code","volume":"18","author":"Yau","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrm.2017.129","article-title":"Building and decoding ubiquitin chains for mitophagy","volume":"19","author":"Harper","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-018-0026-1","article-title":"Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity","volume":"556","author":"Pao","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-981-15-1025-0_5","article-title":"Coordinated actions between p97 and cullin-RING ubiquitin ligases for protein degradation","volume":"1217","author":"Shi","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib18","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/embor.2013.173","article-title":"Building and remodelling Cullin-RING E3 ubiquitin ligases","volume":"14","author":"Lydeard","year":"2013","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2024.107264_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev-biochem-090120-013613","article-title":"Cullin-RING ubiquitin ligase regulatory circuits: a quarter century beyond the F-box hypothesis","volume":"90","author":"Harper","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2024.107264_bib20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature11503","article-title":"Structure-based prediction of protein-protein interactions on a genome-wide scale","volume":"490","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao5902","article-title":"Chemically induced proximity in biology and medicine","volume":"359","author":"Stanton","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107264_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/35104500","article-title":"Auxin regulates SCF(TIR1)-dependent degradation of AUX\/IAA proteins","volume":"414","author":"Gray","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nature03543","article-title":"The F-box protein TIR1 is an auxin receptor","volume":"435","author":"Dharmasiri","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature03542","article-title":"The Arabidopsis F-box protein TIR1 is an auxin receptor","volume":"435","author":"Kepinski","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature05731","article-title":"Mechanism of auxin perception by the TIR1 ubiquitin ligase","volume":"446","author":"Tan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y","article-title":"Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses","volume":"60","author":"Miller","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.jbc.2024.107264_bib27","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","article-title":"The thalidomide saga","volume":"39","author":"Melchert","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4161\/cc.7.9.5793","article-title":"Shedding light on an old mystery: thalidomide suppresses survival pathways to induce limb defects","volume":"7","author":"Knobloch","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2024.107264_bib29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107264_bib30","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2011-05-356063","article-title":"Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide","volume":"118","author":"Zhu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2024.107264_bib31","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2024.107264_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107264_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107264_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjh.12708","article-title":"Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.)","volume":"164","author":"Gandhi","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jbc.2024.107264_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS","volume":"523","author":"Kr\u00f6nke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4(CRBN) ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat0572","article-title":"Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN","volume":"362","author":"Sievers","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107264_bib39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A\u00a0novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15398","article-title":"pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase","volume":"8","author":"An","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107264_bib41","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1021\/jm9902638","article-title":"Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle","volume":"42","author":"Owa","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib42","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0959-8049(01)00275-1","article-title":"E7070, a novel sulphonamide agent with potent antitumour activity in\u00a0vitro and in\u00a0vivo","volume":"37","author":"Ozawa","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jbc.2024.107264_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1010608317361","article-title":"Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells","volume":"19","author":"Fukuoka","year":"2001","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.jbc.2024.107264_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3755","article-title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15","volume":"356","author":"Han","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107264_bib45","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1078-0432.CCR-0109-03","article-title":"An angiogenesis inhibitor E7820 shows broad-spectrum tumor growth inhibition in a xenograft model: possible value of integrin alpha2 on platelets as a biological marker","volume":"10","author":"Semba","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2024.107264_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nchembio.2363","article-title":"Selective degradation of splicing factor CAPER\u03b1 by anticancer sulfonamides","volume":"13","author":"Uehara","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib47","doi-asserted-by":"crossref","first-page":"935","DOI":"10.14348\/molcells.2020.0122","article-title":"Aryl sulfonamides induce degradation of aryl hydrocarbon receptor nuclear translocator through CRL4DCAF15 E3 ligase","volume":"43","author":"Kim","year":"2020","journal-title":"Mol. Cells"},{"key":"10.1016\/j.jbc.2024.107264_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103545","article-title":"pSILAC method coupled with two complementary digestion approaches reveals PRPF39 as a new E7070-dependent DCAF15 substrate","volume":"210","author":"Jia","year":"2020","journal-title":"J.\u00a0Proteomics"},{"key":"10.1016\/j.jbc.2024.107264_bib49","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.str.2019.10.005","article-title":"Structural basis and kinetic pathway of RBM39 recruitment to DCAF15 by a sulfonamide molecular glue E7820","volume":"27","author":"Du","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2024.107264_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41589-019-0378-3","article-title":"Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15","volume":"16","author":"Faust","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41589-019-0411-6","article-title":"Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex","volume":"16","author":"Bussiere","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib52","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41589-020-0594-x","article-title":"Rational discovery of molecular glue degraders via scalable chemical profiling","volume":"16","author":"Mayor-Ruiz","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1158\/2159-8290.CD-19-0528","article-title":"Transcription-Associated cyclin-dependent kinases as targets and biomarkers for cancer therapy","volume":"10","author":"Chou","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2024.107264_bib54","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1242\/dev.091744","article-title":"Cdks, cyclins and CKIs: roles beyond cell cycle regulation","volume":"140","author":"Lim","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.jbc.2024.107264_bib55","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2024.107264_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2024.107264_bib57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-020-2374-x","article-title":"The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K","volume":"585","author":"S\u0142abicki","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib58","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59994","article-title":"Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation","volume":"9","author":"Lv","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2024.107264_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109394","article-title":"Degradation of CCNK\/CDK12 is a druggable vulnerability of colorectal cancer","volume":"36","author":"Dieter","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2024.107264_bib60","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/abbs\/gmaa053","article-title":"The application of ubiquitin ligases in the PROTAC drug design","volume":"52","author":"Chen","year":"2020","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.jbc.2024.107264_bib61","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1039\/D1CC05715D","article-title":"Development of hypoxia-activated PROTAC exerting a more potent effect in tumor hypoxia than in normoxia","volume":"57","author":"Cheng","year":"2021","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.jbc.2024.107264_bib62","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/jacs.9b12718","article-title":"Optical control of small molecule-induced protein degradation","volume":"142","author":"Naro","year":"2020","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107264_bib63","article-title":"Light-induced control of protein destruction by opto-PROTAC","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2024.107264_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay5064","article-title":"PHOTACs enable optical control of protein degradation","volume":"6","author":"Reynders","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2024.107264_bib65","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/acschembio.0c00285","article-title":"Antibody-PROTAC conjugates enable HER2-dependent targeted protein degradation of BRD4","volume":"15","author":"Maneiro","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor \u03b1 in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2024.107264_bib67","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/jacs.1c00451","article-title":"Cancer selective target degradation by folate-caged PROTACs","volume":"143","author":"Liu","year":"2021","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107264_bib68","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1021\/acs.jmedchem.1c00901","article-title":"Folate-guided protein degradation by immunomodulatory imide drug-based molecular glues and proteolysis targeting chimeras","volume":"64","author":"Chen","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib69","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1021\/ja209924v","article-title":"Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL\/HIF-1\u03b1 interaction","volume":"134","author":"Buckley","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107264_bib70","doi-asserted-by":"crossref","first-page":"11463","DOI":"10.1002\/anie.201206231","article-title":"Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1\u03b1","volume":"51","author":"Buckley","year":"2012","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"10.1016\/j.jbc.2024.107264_bib71","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective small molecule induced degradation of the BET bromodomain protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib72","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/acs.jmedchem.8b01572","article-title":"Discovery of ERD-308 as a highly potent proteolysis targeting chimera (PROTAC) degrader of estrogen receptor (ER)","volume":"62","author":"Hu","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib73","doi-asserted-by":"crossref","first-page":"16930","DOI":"10.1021\/jacs.2c05499","article-title":"Discovery of XL01126: a potent, fast, cooperative, selective, orally bioavailable, and blood\u2013brain barrier penetrant PROTAC degrader of leucine-rich repeat kinase 2","volume":"144","author":"Liu","year":"2022","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107264_bib74","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in\u00a0vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107264_bib75","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2019.01.023","article-title":"A\u00a0novel cereblon modulator for targeted protein degradation","volume":"166","author":"Kim","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib77","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1021\/acschembio.9b00704","article-title":"Development of small molecule chimeras that recruit AhR E3 ligase to target proteins","volume":"14","author":"Ohoka","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib78","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41467-023-44237-4","article-title":"DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance","volume":"15","author":"Schr\u00f6der","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107264_bib79","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/jacs.1c00990","article-title":"DCAF11 supports targeted protein degradation by electrophilic proteolysis-targeting chimeras","volume":"143","author":"Zhang","year":"2021","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107264_bib80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-020-00245-0","article-title":"In\u00a0vivo target protein degradation induced by PROTACs based on E3 ligase DCAF15","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2024.107264_bib81","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41589-019-0279-5","article-title":"Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16","volume":"15","author":"Zhang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib82","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/jacs.1c03980","article-title":"Discovery of a covalent FEM1B recruiter for targeted protein degradation applications","volume":"144","author":"Henning","year":"2022","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107264_bib83","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1074\/jbc.M116.768853","article-title":"In\u00a0vivo knockdown of pathogenic proteins via specific and nongenetic inhibitor of apoptosis protein (IAP)-dependent protein erasers (SNIPERs)","volume":"292","author":"Ohoka","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib84","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/acschembio.8b01094","article-title":"PROTAC-mediated degradation of bruton's tyrosine kinase is inhibited by covalent binding","volume":"14","author":"Tinworth","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112397","article-title":"Discovery of IAP-recruiting BCL-XL PROTACs as potent degraders across multiple cancer cell lines","volume":"199","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127106","article-title":"Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs","volume":"30","author":"Anderson","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2024.107264_bib87","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/acsmedchemlett.1c00629","article-title":"Development of chimeric molecules that degrade the estrogen receptor using decoy oligonucleotide ligands","volume":"13","author":"Naganuma","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2024.107264_bib88","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/acs.biochem.2c00288","article-title":"Comprehensive transcriptomic analysis of novel class I HDAC proteolysis targeting chimeras (PROTACs)","volume":"62","author":"Baker","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2024.107264_bib89","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","article-title":"Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway","volume":"146","author":"Lu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib90","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1021\/jacs.1c04841","article-title":"Harnessing the E3 ligase KEAP1 for targeted protein degradation","volume":"143","author":"Wei","year":"2021","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107264_bib91","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.chembiol.2022.08.003","article-title":"Exploring the target scope of KEAP1 E3 ligase-based PROTACs","volume":"29","author":"Du","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.chembiol.2023.01.004","article-title":"Piperlongumine conjugates induce targeted protein degradation","volume":"30","author":"Pei","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib93","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.chembiol.2023.07.008","article-title":"Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligase","volume":"30","author":"Kim","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib94","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.chembiol.2023.07.006","article-title":"Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, \u03b2-catenin, and FoxP3","volume":"30","author":"R\u00f6th","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41594-023-01146-w","article-title":"Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules","volume":"31","author":"Hickey","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib96","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.bmcl.2008.07.114","article-title":"Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics","volume":"18","author":"Schneekloth","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2024.107264_bib97","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1158\/0008-5472.CAN-18-2918","article-title":"MDM2-Recruiting PROTAC offers superior, synergistic antiproliferative activity via simultaneous degradation of BRD4 and stabilization of p53","volume":"79","author":"Hines","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2024.107264_bib98","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1021\/acs.jmedchem.9b00846","article-title":"Simple structural modifications converting a bona fide MDM2 PROTAC degrader into a molecular glue molecule: a cautionary tale in the design of PROTAC degraders","volume":"62","author":"Yang","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib99","first-page":"333","article-title":"MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53","volume":"1","author":"Chang","year":"2022","journal-title":"Acta Mater. Med."},{"key":"10.1016\/j.jbc.2024.107264_bib100","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/acschembio.0c00348","article-title":"A\u00a0nimbolide-based kinase degrader preferentially degrades oncogenic BCR-ABL","volume":"15","author":"Tong","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib101","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.chembiol.2021.01.005","article-title":"Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function","volume":"28","author":"Luo","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib102","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1021\/acschembio.8b01083","article-title":"Covalent ligand screening uncovers a RNF4 E3 ligase recruiter for targeted protein degradation applications","volume":"14","author":"Ward","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib103","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1021\/acs.jmedchem.2c00728","article-title":"Homobivalent, trivalent, and covalent PROTACs: emerging strategies for protein degradation","volume":"65","author":"Yan","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","article-title":"Mechanisms of deubiquitinase specificity and regulation","volume":"86","author":"Mevissen","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2024.107264_bib105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0092-8674(95)90240-6","article-title":"Degradation of CFTR by the ubiquitin-proteasome pathway","volume":"83","author":"Ward","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107264_bib106","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12551-021-00915-5","article-title":"Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy","volume":"14","author":"Hibino","year":"2022","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.jbc.2024.107264_bib107","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/gutjnl-2015-309322","article-title":"hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation","volume":"66","author":"Hu","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jbc.2024.107264_bib108","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.7150\/jca.61996","article-title":"The E3 ubiquitin ligase HOIP inhibits cancer cell apoptosis via modulating PTEN stability","volume":"12","author":"Niu","year":"2021","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.jbc.2024.107264_bib109","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41418-020-00606-w","article-title":"TRIM22 activates NF-\u03baB signaling in glioblastoma by accelerating the degradation of I\u03baB\u03b1","volume":"28","author":"Ji","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2024.107264_bib110","doi-asserted-by":"crossref","first-page":"12934","DOI":"10.1021\/jacs.2c04824","article-title":"TF-DUBTACs stabilize tumor suppressor transcription factors","volume":"144","author":"Liu","year":"2022","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2024.107264_bib111","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature19836","article-title":"Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne","volume":"538","author":"Mevissen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107264_bib112","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molcel.2016.05.009","article-title":"MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes","volume":"63","author":"Abdul Rehman","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.107264_bib113","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1016\/j.molcel.2021.08.024","article-title":"Mechanism of activation and regulation of deubiquitinase activity in MINDY1 and MINDY2","volume":"81","author":"Abdul Rehman","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2024.107264_bib114","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","article-title":"OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis","volume":"154","author":"Mevissen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107264_bib115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/1535-7163.MCT-19-0270","article-title":"Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer","volume":"19","author":"Santoro","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107264_bib116","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12964-020-00604-y","article-title":"FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1","volume":"18","author":"Shi","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jbc.2024.107264_bib117","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/cdd.2016.143","article-title":"Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63- mediated polyubiquitination","volume":"24","author":"Jeon","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2024.107264_bib118","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1083\/jcb.200401141","article-title":"AMSH is an endosome-associated ubiquitin isopeptidase","volume":"166","author":"McCullough","year":"2004","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib119","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/emboj.2009.27","article-title":"K63-specific deubiquitination by two JAMM\/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1","volume":"28","author":"Cooper","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2024.107264_bib120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","article-title":"SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate","volume":"14","author":"Matyskiela","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib121","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/acs.jmedchem.6b01921","article-title":"A\u00a0cereblon modulator (CC-220) with improved degradation of ikaros and aiolos","volume":"61","author":"Matyskiela","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib122","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/blood-2015-02-628669","article-title":"CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL","volume":"126","author":"Hagner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2024.107264_bib123","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2021.02.110","article-title":"Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myeloma","volume":"549","author":"Zhao","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2024.107264_bib124","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.omto.2020.06.013","article-title":"A\u00a0cereblon modulator CC-885 induces CRBN- and p97-dependent PLK1 degradation and synergizes with volasertib to suppress lung cancer","volume":"18","author":"Li","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.jbc.2024.107264_bib125","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1021\/acs.jmedchem.9b01928","article-title":"Discovery of CRBN E3 ligase modulator CC-92480 for the treatment of relapsed and refractory multiple myeloma","volume":"63","author":"Hansen","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib126","article-title":"Identification of MRT-2359 a potent, selective and orally bioavailable GSPT1-directed molecular glue degrader (MGD) for the treatment of cancers with Myc-induced translational addiction [abstract]","volume":"82","author":"Gavory","year":"2022"},{"key":"10.1016\/j.jbc.2024.107264_bib127","doi-asserted-by":"crossref","first-page":"11802","DOI":"10.1073\/pnas.1814446115","article-title":"Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs","volume":"115","author":"Gemechu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107264_bib128","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1021\/acs.jmedchem.9b00454","article-title":"De-novo design of cereblon (CRBN) effectors guided by natural hydrolysis products of thalidomide derivatives","volume":"62","author":"Heim","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105923","article-title":"Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model","volume":"127","author":"Takwale","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2024.107264_bib131","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood.2020008676","article-title":"CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells","volume":"137","author":"Surka","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2024.107264_bib132","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41401-020-0367-9","article-title":"The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L","volume":"41","author":"Hao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jbc.2024.107264_bib133","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41467-024-44698-1","article-title":"Selective CK1\u03b1 degraders exert antiproliferative activity against a broad range of human cancer cell lines","volume":"15","author":"Nishiguchi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107264_bib134","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/acschembio.0c00674","article-title":"Cereblon modulators target ZBTB16 and its oncogenic fusion partners for degradation via distinct structural degrons","volume":"15","author":"Matyskiela","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41589-021-00802-w","article-title":"Acute pharmacological degradation of Helios destabilizes regulatory T cells","volume":"17","author":"Wang","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib136","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1021\/acs.jmedchem.1c01832","article-title":"Development of PDE6D and CK1\u03b1 degraders through chemical derivatization of FPFT-2216","volume":"65","author":"Teng","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2024.107264_bib137","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.chembiol.2023.02.005","article-title":"Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy","volume":"30","author":"Bonazzi","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib138","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/acschembio.0c00520","article-title":"Selective degradation of GSPT1 by cereblon modulators identified via a focused combinatorial library","volume":"15","author":"Powell","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib139","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1021\/acschembio.3c00598","article-title":"Discovery of molecular glue degraders via isogenic morphological profiling","volume":"18","author":"Ng","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/acschembio.2c00747","article-title":"CRISPR screen reveals BRD2\/4 molecular glue-like degrader via recruitment of DCAF16","volume":"18","author":"Shergalis","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib141","article-title":"Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues","author":"Hassan","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2024.107264_bib142","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1535-7163.MCT-18-1129","article-title":"Acquired resistance to BET-PROTACs (proteolysis-targeting chimeras) caused by genomic alterations in core components of E3 ligase complexes","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2024.107264_bib143","first-page":"2215","article-title":"Cellular resistance mechanisms to targeted protein degradation converge toward impairment of the engaged ubiquitin transfer pathway","volume":"14","author":"Ottis","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jbc.2024.107264_bib144","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111391118","article-title":"USP15 antagonizes CRL4CRBN-mediated ubiquitylation of glutamine synthetase and neosubstrates","volume":"118","author":"Nguyen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824017654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824017654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T21:35:44Z","timestamp":1716845744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824017654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":144,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0021925824017654"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107264","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of protein ubiquitylation and deubiquitylation in drug discovery","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107264"}}